Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open-label, single-arm, phase 1/2 study on 10 Japanese patients

导出原文传递

翻译打印收藏纠错

作者： Kurihara, Yuichi ^[1] ; Yamagami, Jun ^[2] ; Funakoshi, Takeru ^[3] ; Ishii, Maki ^[4] ; Miyamoto, Julia ^[5] ; Fujio, Yumi ; Kakuta, Risa ; Tanikawa, Akiko ; Aoyama, Yumi ; Iwatsuki, Keiji ; Ishii, Norito ; Hashimoto, Takashi ; Nishie, Wataru ; Shimizu, Hiroshi ; Kouyama, Keisuke ; Amagai, Masayuki

作者单位： Okayama Univ, Sch Med, Dept Dermatol, Okayama, Japan ^[1] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan ^[2] Keio Univ Hosp, Clin & Translat Res Ctr, Tokyo, Japan ^[3] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka, Japan ^[4] Hokkaido Univ, Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan ^[5]

关键词 CD20 antigens immunotherapy pemphigoid pemphigus rituximab

发布时间 2019-04-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交